These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 20476596)
1. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors]. Smoleń A; Stachowicz N; Czekierowski A; Kotarski J Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596 [TBL] [Abstract][Full Text] [Related]
2. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements. Czekierdowski A Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913 [TBL] [Abstract][Full Text] [Related]
3. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor. Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561 [TBL] [Abstract][Full Text] [Related]
4. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475 [TBL] [Abstract][Full Text] [Related]
5. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses. Timmerman D; Verrelst H; Bourne TH; De Moor B; Collins WP; Vergote I; Vandewalle J Ultrasound Obstet Gynecol; 1999 Jan; 13(1):17-25. PubMed ID: 10201082 [TBL] [Abstract][Full Text] [Related]
6. [Use of multilayer perception artificial neutral networks for the prediction of the probability of malignancy in adnexal tumors]. Smoleń A; Czekierdowski A; Stachowicz N; Kotarski J Ginekol Pol; 2003 Sep; 74(9):855-62. PubMed ID: 14674136 [TBL] [Abstract][Full Text] [Related]
7. Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models. Marret H; Ecochard R; Giraudeau B; Golfier F; Raudrant D; Lansac J Ultrasound Obstet Gynecol; 2002 Dec; 20(6):597-604. PubMed ID: 12493050 [TBL] [Abstract][Full Text] [Related]
8. An improved risk of malignancy index in diagnosis of adnexal mass. Wang LM; Song H; Song X; Zhou XB Chin Med J (Engl); 2012 Feb; 125(3):533-5. PubMed ID: 22490416 [TBL] [Abstract][Full Text] [Related]
9. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses? Jokubkiene L; Sladkevicius P; Valentin L Ultrasound Obstet Gynecol; 2007 Feb; 29(2):215-25. PubMed ID: 17201017 [TBL] [Abstract][Full Text] [Related]
10. Color and pulsed Doppler sonography, gray-scale imaging, and serum CA 125 in the assessment of adnexal disease. Predanic M; Vlahos N; Pennisi JA; Moukhtar M; Aleem FA Obstet Gynecol; 1996 Aug; 88(2):283-8. PubMed ID: 8692517 [TBL] [Abstract][Full Text] [Related]
11. The risk of malignancy index in discrimination of adnexal masses. Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665 [TBL] [Abstract][Full Text] [Related]
12. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334 [TBL] [Abstract][Full Text] [Related]
13. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease. Salem S; White LM; Lai J AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891 [TBL] [Abstract][Full Text] [Related]
14. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer. Varras M Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758 [TBL] [Abstract][Full Text] [Related]
15. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor]. Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441 [TBL] [Abstract][Full Text] [Related]
16. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass. Dora SK; Dandapat AB; Pande B; Hota JP J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975 [TBL] [Abstract][Full Text] [Related]
18. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses. Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547 [TBL] [Abstract][Full Text] [Related]
19. Role of a risk of malignancy index in clinical approaches to adnexal masses. Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065 [TBL] [Abstract][Full Text] [Related]
20. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]